This webcast discusses economic issues related to TAVR and the associated implications for provision of TAVR procedures in various settings.

This webcast will focus on indications for intermediate risk TAVR patients and emerging clinical evidence from major TAVR trials.

This program covers TMVR clinical trial design, appropriate patient selection and screening, and optimal care. Gain the knowledge needed for these new therapies from expert faculty in an interactive program.

This webcast will help clinicians develop a refined understanding of residual CVD risk in hypercholesterolemic patients and allow them to adjust prescribing behavior to reduce risk as much as possible.

This program features slides and a transcription of the speakers’ presentations from a live meeting held on October 30, 2017. Internationally renowned experts discuss the clinical issues and recent data regarding antiplatelet/anticoagulation in patients with coronary artery disease (CAD).